Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Nanjing Ruijie Pharma identifies tyrosine-protein kinase SYK inhibitors

Dec. 27, 2021

New Ex20Ins mutant EGFR inhibitors decribed by Inventisbio Shanghai

Dec. 27, 2021

New USP30 inhibitors identified at Mission Therapeutics

Dec. 24, 2021

Janssen Pharmaceutica synthesizes new Mcl-1 inhibitors

Dec. 24, 2021

Trinuero, DGMIF identify SERT, NET and DAT inhibitors

Dec. 24, 2021

CSIPI and Shanghai Zhongze Therapeutics patent dopamine D2/D3/5-HT2A receptor antagonists

Dec. 24, 2021

Dual PI3K/BRD4 inhibitors divulged by Monash University, Peter MacCallum Cancer Centre

Dec. 24, 2021

Yumanity Therapeutics discloses PIKfyve inhibitors

Dec. 23, 2021

KSQ Therapeutics synthesizes USP1 inhibitors

Dec. 23, 2021

Gilead Sciences identifies new LPAR1 antagonists

Dec. 23, 2021

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...